Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer

NCT02055170 is registered in ClinicalTrials.gov with CancerCare Manitoba as lead sponsor.

NCT NCT02055170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02055170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer
Lead sponsor
CancerCare Manitoba
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2014
Completion date
March 27, 2018
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer